Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Neurosteroids show promise for treating epilepsy and more research is needed.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Finasteride helps reduce heart issues and improves heart function.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Melatonin may help treat PCOS symptoms in rats.